NDC 63323-751-00 - Phenylephrine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-751
- Requested NDC
- 63323-751-00
- Package NDCs from labels
- 63323-751-05, 63323-751-10, 63323-751-00, 63323-751-01, 63323-751-03, 63323-751-13
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2026-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| PHENYLEPHRINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-751-00 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 8 | |
| 63323-751-01 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 8 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 5 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 5 | 4 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 10 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 10 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-03 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 2 | |
| 63323-751-13 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20231208_1e77b9c8-fa17-4aa4-adc8-ff716ab2e5d7.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 4 package rows | 20240125_c7026b15-1228-4acb-beed-4474fcdbb972.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240110_f2dce7f1-6538-4747-9792-665eee45c0a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-751-00 | ML - Milliliter | 63323-751 | 1394c34e-4c42-4094-b1b2-afcdc13e132b | 1 | 2019-07-02 |
| 63323-751-01 | ML - Milliliter | 63323-751 | a8b40ddc-6423-477a-9e40-f4a05b934ade | 1 | 2019-07-02 |
| 63323-751-03 | ML - Milliliter | 63323-751 | cf951bf5-4a25-4cb0-9c6b-c9e4c8cb2180 | 1 | 2020-08-06 |
| 63323-751-05 | ML - Milliliter | 63323-751 | 321cea9d-af97-405d-9cb3-812f3c5e23d3 | 1 | 2019-07-02 |
| 63323-751-10 | ML - Milliliter | 63323-751 | 9610d875-e8cc-4c7b-83b7-8b4ebf6a4e9e | 1 | 2019-07-02 |
| 63323-751-13 | ML - Milliliter | 63323-751 | ec8453b5-99f8-4776-90d2-3d17719905cf | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| equate cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | WALMART INC. | e83d14cc-9b90-40ce-a00a-2702d8a8968f | 2026-04-17 | Warnings | 04JA59TNSJ |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Equaline Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | United Natural Foods, Inc. dba UNFI | a6ed1987-37ad-4bfd-8cea-f03426953f5a | 2026-04-16 | Warnings | 04JA59TNSJ |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Valu Merchandisers Company | cdcb8e0d-7847-4f28-bb09-7dc7b5d35c13 | 2026-04-16 | Warnings | 04JA59TNSJ |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Cold Multi-Symptom Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Valu Merchandisers Company | b0d9d869-9f0d-4834-aa2b-1ee21fd8b67b | 2026-04-16 | Warnings | 04JA59TNSJ |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Sinus and Headache | ACETAMINOPHEN, PHENYLEPHRINE HCL | Walgreen Company | 2115f095-2d75-4e02-a6af-22dd693e0840 | 2026-04-14 | Warnings | 04JA59TNSJ |
| daytime severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 5515148f-3e1d-4b03-89fa-40967d508292 | 2026-04-14 | Warnings | 04JA59TNSJ |
| Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE | LABORATORIOS GRIFOLS SA | db8334be-5b8b-4811-811a-efbe32b6d147 | 2026-04-14 | Warnings | B22547B95K |
| Mucus Relief Sinus Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | c70e6506-6c5b-4d3f-ab18-a690840caabc | 2026-04-13 | Warnings | 04JA59TNSJ |
| Nasal Decongestant PE | PHENYLEPHRINE HCL | Walgreen Company | 48387b95-8240-4d6e-842b-cc29cc18709c | 2026-04-13 | Warnings | 04JA59TNSJ |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| Nitrogen | NITROGEN | Messer LLC | c6f2772a-e53a-c379-b99e-a4f7c3e82f60 | 2026-04-13 | N762921K75 | |
| Severe Sinus Congestion | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Walgreen Company | 8745d9d8-640d-4e3b-96fe-d25032c1e3ce | 2026-04-13 | Warnings | 04JA59TNSJ |
| Phenylephrine hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Par Health USA, LLC | d92631a6-bae8-493b-b4df-c563346607a8 | 2026-04-13 | Warnings, Adverse reactions | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.